GHTM

Global Health and Tropical Medicine

  • GHTM
    • Vision
    • Mission
    • Governance
    • Scientific Advisory Board
  • News
    • Outreach
    • Events
      • GHTM Sessions
      • Workshops
    • Articles
    • Jobs
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases and pathogens
      • IHC – Individual health care
    • Research in numbers
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases and pathogens
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Technical / administrative support
  • Publications
  • Education
    • Master Theses
    • PhD Theses
  • Services
Home / Perfis / Marcelo Sousa Silva
  • +351 213 652 600
  • +351 213 632 105
  • Enviar Mail
  • Download CV
  • Orcid
  • NOVA Research

Marcelo Sousa Silva

Assistant Researcher

Grupo GHTM: GHTM former members

ProfileResearchTop 5 Publications

Marcelo Sousa Silva is Permanent Professor at the Faculty of Pharmacy at the Federal University of Rio Grande do Norte (UFRN, Natal, Brazil). He is Permanent Member of the Post-graduate Program in Pharmaceutical Sciences and the Post-graduate Program in Biochemistry and Molecular Biology, both at UFRN-Brazil. He is Research Fellow at CNPq-Brasil, Coordinator of the Post-graduate Program in Pharmaceutical Sciences at UFRN and Coordinator of the Parasitology and Immunology discipline of the Pharmacy graduate course. Marcelo Silva has a PhD in Biotechnology (IST-UTL-Portugal, 2006), MSc in Biotechnology (USP-Brazil, 2001) and Graduation in Pharmaceutical Sciences (UFRN-Brazil, 1999). During his degree, he was a Research Fellowship at the Instituto Butantan (http://www.butantan.gov.br) and at the University of São Paulo (http://www5.usp.br). He developed his Post-doctoral at the Centro de Biologia Molecular Severo Ochoa – Universidad Autónoma de Madrid (Spain, 2007) and at the Instituto de Higiene e Medicina Tropical – Universidade Nova de Lisboa (IHMT-UNL-Portugal, from 2007 to 2012). His main lines of research are related to immunopathogenesis, evaluation of drugs and vaccines in the context of tropical diseases caused by protozoa (malaria, Chagas disease, leishmaniasis and sleeping sickness).

ORCID ID: orcid.org/0000-0002-1000-0149

CNPq CV: http://lattes.cnpq.br/1295430560645312

 

Main lines of research are related to:

  • Immunopathogenesis;
  • Experimental models of infectious diseases
  • Evaluation of drugs and vaccines;
  • Tropical diseases (malaria, Chagas disease, leishmaniasis and sleeping sickness).

 

  1. de Freitas-Oliveira JW, da Silva MFA, Damasceno IZ, Rocha HAO, da Silva Júnior AA, Silva MS. In Vitro Validation of Antiparasitic Activity of PLA-Nanoparticles of Sodium Diethyldithiocarbamate against Trypanosoma cruzi. PHARMACEUTICS, v. 14, p. 497-511, 2022.
  2. Oliveira, J. W. F. ; Torres, T. M. ; Moreno, C. J. G. ; Amorim-Carmo, B. ; Damasceno, I. Z. ; Soares, A. K. M. C. ; Barbosa, J. S. ; Rocha, H. A. O. ; Silva, M. S. . Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi. Scientific Reports, v. x, p. 1-15, 2021.
  3. Queiroz, A. M. V. ; Yanshina, Y. A. ; Rodrigues, E. T. S. ; Santos, F. L. N. ; Celedon, P. A. F. ; Maheshwari, S. ; Gabelli, S. B. ; Rubio, C. S. P. ; Durana, A. ; Guerin, D. M. A. ; Silva, M. S. . Antibodies response induced by recombinant virus-like particles from Triatoma virus and chimeric antigens from Trypanosoma cruzi. VACCINE, v. xxx, p. 1-12, 2021.
  4. Antunes ML, Seixas J, Ferreira HE, Silva MS. Adequacy of severe malaria markers and prognostic scores in an Intensive Care Unit in Luanda, Angola: A clinical study. Clin. Med., 9: 3862-3874, 2020.
  5. Domingos J, Casimiro A, Portugal-Calisto D, Varandas L, Nogueira F, Silva MS. Clinical, laboratorial and immunological aspects of severe malaria in children from Guine-Bissau. Acta Trop., 185: 46-51, 2018.

About GHTM

GHTM is a R&D Center that brings together researchers from IHMT with a track record in Tropical Medicine and International/Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal
+351 213 652 600
+351 213 632 105

  • Facebook
  • YouTube

Subscribe Newsletter

  • How to get to GHTM/IHMT
  • GHTM Sessions
  • Research Groups
  • Cross-cutting issues
© Copyright 2023 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013